IA
TRPX

IFP Advisors’s Therapix Biosciences Ltd. TRPX Stock Holding History

IFP Advisors’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20
Closed – – 3770
2018
Q4 		$0 Sell
20
-70
-78% -$406 ﹤0.01% 4006
2018
Q3 		$0 Sell
90
-100
-53% -$388 ﹤0.01% 4115
2018
Q2 		$1K Buy
190
+100
+111% +$454 ﹤0.01% 3819
2018
Q1 		$0 Hold
90
– – ﹤0.01% 3880
2017
Q4 		$0 Hold
90
– – ﹤0.01% 4239
2017
Q3 		$1K Hold
90
– – ﹤0.01% 4004
2017
Q2 		$1K Buy
+90
New +$626 ﹤0.01% 4000

Other funds holding TRPX

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

IFP Advisors's TRPX Position: Q1 2019 in Review

IFP Advisors sold out of Therapix Biosciences Ltd. (TRPX) in Q1 2019, closing a stake of 20 shares.

IFP Advisors first reported a position in TRPX in Q2 2017 and held it in 7 quarters. The position peaked at $1K in Q2 2018. 4 funds tracked by Wall St. Rank hold TRPX as of Q1 2019.

  • IFP Advisors reported no remaining Therapix Biosciences Ltd. position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 20 Therapix Biosciences Ltd. shares in Q1 2019.
  • IFP Advisors first reported a position in Therapix Biosciences Ltd. in Q2 2017 and held it in 7 quarters.
  • IFP Advisors's Therapix Biosciences Ltd. position peaked at $1K in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.